DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

161.51 0.92 (0.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRX $161.51 0.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $160.07
Previous Close $160.59
Daily Range $158.60 - $161.79
52-Week Range $106.00 - $162.80
Market Cap $54.2B
P/E Ratio 104.28
Dividend (Yield) $0.00 (0.0%)
Volume 1,383,583
Average Daily Volume 2,065,147
Current FY EPS $2.96

Sector

Healthcare

Industry

Drugs

Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

News & Commentary

Top Pharmaceutical Stocks to Buy for 2015

Three fast-growing pharmaceutical stocks that investors may want to consider owning in 2015.

3 Stocks Boosting The Drugs Industry Higher

New Guru Jana Partners' Newest Stock Buys

A Look At Actavis

Valeant's Bausch + Lomb Imaging System Cleared by FDA - Analyst Blog

Why Valeant Pharmaceuticals (VRX) Isn't Done Growing Earnings Yet - Tale of the Tape

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formular

UPDATE: Morgan Stanley Reiterates, Raises Price Target On Valeant Pharmaceuticals As Jublia Formulary Concerns Are Noise

Valeant CEO On Allegations Against The Company And Future M&A Deals

New Lifetime High Today: Valeant Pharmaceuticals International (VRX)

Valeant Pharmaceuticals, A Bet The Jockey Story With Upside

Analysts Make Bullish Ratings in Response to Valeant's Increased 2015 Guidance

See More VRX News...

VRX's Top Competitors

VRX $161.51 (0.57%)
Current stock: VRX
JNJ $102.38 (0.89%)
Current stock: JNJ
NVS $99.16 (2.11%)
Current stock: NVS
RHHBY $34.38 (-0.28%)
Current stock: RHHBY